Sort
15,842 grants matching “pancreatic cancer”
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$100,528Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2025 · CA
Identifying Metabolic Vulnerabilities in Pancreatic Cancer
$100,486Douglas Biancur · New York University School Of Medicine · K00 · FY2023 · CA
11 Solid Tumor Therapeutics Program
$100,450Timothy J Eberlein · Washington University · P30 · FY2024 · CA
11 Solid Tumor Therapeutics Program
$100,450Timothy J Eberlein · Washington University · P30 · FY2023 · CA
11 Solid Tumor Therapeutics Program
$100,450Timothy J Eberlein · Washington University · P30 · FY2022 · CA
Community Outreach Core
$100,378Sandra G Suther · Florida Agricultural And Mechanical Univ · U54 · FY2025 · CA
The Role of post-translational activation of Myc in pancreatic cancer
$100,339Rosalie C Sears · Oregon Health & Science University · R01 · FY2018 · CA
Career Program
$100,288Scott E Kern · Johns Hopkins University · P50 · FY2013 · CA
Administrative Core
$100,237Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA
QNMR system for whole body composition analysis of live mice
$100,106Nicholas Gekakis · Scripps Research Institute, The · S10 · FY2011 · RR
CORE--CELL
$100,068Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2008 · CA
Production and use of Pb-203 for cancer therapy research
$100,038Alphamed, Inc · R43 · FY2005 · CA
The Stanford Clinical Center for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer
$100,000Walter Gwang-Up Park · Stanford University · U01 · FY2022 · DK
Gq-coupled Receptors Inhibit PI 3-kinase/Akt Signaling Pathway
$100,000Richard Z Lin · State University New York Stony Brook · R01 · FY2010 · DK
Development of Immunodiagnostics for Pancreatic Cancer
$100,000Panacea Pharmaceuticals, Inc. · R43 · FY2002 · CA
Selective Targeting of MEK and AKt in Lymphoma and Myeloma Apoptosis
$100,000Gregory B Carey · University Of Maryland Baltimore · K22 · FY2009 · CA
Plasmin-activated Prodrug Therapy for Pancreatic Cancer
$100,000David Jay Burkhart · Serendipity Pharmaceuticals, Inc. · R41 · FY2006 · CA
NOVEL RAS ANTAGONISTS FOR TREATMENT OF HUMAN CANCER
$100,000Thyreos Corporation · R43 · FY2000 · CA
Comprehensive Cancer Center Core Support Grant
$100,000Edward E Partridge · University Of Alabama At Birmingham · P30 · FY2010 · CA
Target Validation using Gene Knockouts in Somatic Cells
$100,000Pangenex, Inc. · R43 · FY2002 · CA
NEW DIAGNOSTIC ASSAY FOR PANCREATIC CANCER
$100,000Glycobiotics, Inc. · R43 · FY2000 · CA
Targeted Delivery of Gemcitabine of Pancreatic Tumors
$100,000Ferx, Inc. · R43 · FY2003 · CA
DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCER
$100,000William E Fisher · Baylor College Of Medicine · U01 · FY2024 · DK
THE AGRICULTURAL HEALTH STUDY - FIELD STATIONS
$100,000Charles F Lynch · University Of Iowa · N01 · FY2010 · CA
Early Detection of Pancreatic Cancer Using Ice COLD-PCR
$100,000Grant Wu · Transgenomic, Inc. · R41 · FY2012 · TR